Highlander Health: Data-Driven Innovation in Medicine
Podcast Episode · Healthcare Unfiltered · 02/10/2025 · 41m
Podcast Episode · Healthcare Unfiltered · 02/10/2025 · 41m
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA Division of Cardiovascular Medicine, Beth Israel Deaconess…
Travere Therapeutics will submit a supplemental New Drug Application to the FDA requesting approval of sparsentan (Filspari) to treat focal segmental glomerulosclerosis (FSGS).
Patients with cancer and caregivers “experience substantial and diverse impacts” on their ability to work, according to a recent study.
The Leukemia & Lymphoma Society Denounces Federal Actions that Threaten Cancer Patients > Page Components
Stephen V. Liu, MD, discusses the randomized phase 2 COCOON trial, which is evaluating a prophylactic dermatologic regimen with amivantamab plus lazertinib in NSCLC.
Researchers assessed barriers to chimeric antigen receptor (CAR) T-cell therapy for patients with non-Hodgkin lymphoma (NHL) in a community-based network and found that 41% of…
AbstractBackgroundDoxorubicin (DOX), a commonly used anticancer agent, can result in cardiac dysfunction, presenting a significant clinical challenge. DOX has been shown to induces Ca2+ leakage…
A recent study found that one key to gut health is eating a wide variety of plants. In this episode, we talk about the research…
What is a vegan? Here’s what veganism is, what benefits it provides and some of the downsides associated with practicing the lifestyle.
Highlights •Therapeutic development for PAD has been largely stagnant for the past 2 decades, and promising preclinical targets have failed to translate into clinical practice.•Preclinical…